Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias.
暂无分享，去创建一个
S. Armstrong | A. Ferrando | J. Teruya-Feldstein | D. Lipson | C. Mullighan | R. Levine | G. Chiosis | Efthymia Papalexi | M. Tallman | A. Krivtsov | N. Bhagwat | E. Paietta | J. Rowe | S. Ochiana | M. Kleppe | Kai Wang | Jié He | P. Stephens | P. Koppikar | S. Marubayashi | E. Papalexi | N. Kucine | M. Sánchez Martín | L. Dong | K. Wang | J. He | V. Miller | L. Leung | Lauren Dong | V. Miller | Priya Koppikar | Stefan O. Ochiana | Sachie Marubayashi | Laura Leung | Marta Sanchez Martin | Marty S Tallman | S. Armstrong | R. Levine